Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TG Therapeutics Inc (NASDAQ:TGTX)

11.40
Delayed Data
As of Mar 24
 +0.50 / +4.59%
Today’s Change
4.10
Today|||52-Week Range
15.05
+145.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-20.5M-55.8M-62.9M-78.3M
 
 
 
 
 
Depreciation1.1K3.9K15.5K63.0K
 
 
 
 
 
Total Other Cash Flow5.5M26.8M16.2M7.8M
 
 
 
 
 
Funds From Operations-15.0M-29.0M-46.8M-70.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-4.2M6.0M-2.1M-8.8M
 
 
 
 
 
Net Cash Flow - Operating Activities-10.8M-35.1M-44.7M-61.6M
 
 
 
 
 
 
InvestingIncrease In Investments-4.9M-18.3M-49.0M-15.2M
 
 
 
 
 
Decrease In Investments0.000.0024.4M42.1M
 
 
 
Capital Expenditures-5.7K-18.6K-42.2K-344.0K
 
 
 
 
 
Net Cash Flow Investing-4.9M-18.4M-24.7M26.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00-677.8K0.000.00
 
 
Long Term Borrowings0.00-52.0K0.00-13.5K
 
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale39.9M69.4M68.8M5.0M
 
 
 
 
 
Common Preferred Redeemed-149.8K0.000.000.00
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.00--0.00--
Other Uses - Financing0.000.00104.2K0.00
 
 
Net Cash Flow - Financing39.8M68.6M68.7M5.0M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash24.0M15.2M-648.3K-30.0M